Author(s):
Joe Chou, Roger Lai, Jason Chou, Shelly Fu, Wei-Hsuan Wang
Email(s):
a0968288562@gmail.com
DOI:
10.52711/0975-4377.2024.00037 
Address:
Joe Chou1, Roger Lai2, Jason Chou1, Shelly Fu2, Wei-Hsuan Wang1
1YQ Biotech Ltd., Taiwan.
2Isuzu Optics Ltd., Taiwan.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2024
ABSTRACT:
The success of a new drug development relies not only on early-stage drugs screening and preclinical animal studies but also PK/PD prediction prior to clinical study. In drug dosage design, the oral formulation is still the most commonly needed due to its convenience in administration. A number of recent reports in new drugs development have pointed out that PBPK modeling of ADME may lead to better prediction of bioavailability. In order to improve the development of NDA oral formulation, an alternative method using FDA approved PK data base and PAMPA Dissolution is proposed upon “similar PK parameters, similar PK profile” which is believed to potentially shorten the research time and reduce the clinical risk in NDA formulation development.
Cite this article:
Joe Chou, Roger Lai, Jason Chou, Shelly Fu, Wei-Hsuan Wang. Pampa Dissolution：An Alternative Method for Oral NDA Formulation Development. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(3):233-7. doi: 10.52711/0975-4377.2024.00037
Cite(Electronic):
Joe Chou, Roger Lai, Jason Chou, Shelly Fu, Wei-Hsuan Wang. Pampa Dissolution：An Alternative Method for Oral NDA Formulation Development. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(3):233-7. doi: 10.52711/0975-4377.2024.00037 Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-3-6
REFERENCES：
1. Guidance for Industry: Exposure-Response Relationships — Study Design, Data Analysis, and Regulatory Applications. Center for Drug Evaluation and Research (CDER), USFDA, 2003.
2. Bhagyashree L. Jejurikar, Sachin H. Rohane. Drug Designing in Discovery Studio. Asian J. Research Chem. 2021; 14(2):135-138.
3. Uday M. Satpute, Sachin H. Rohane. Efficiency of AUTODOCK: Insilico study of Pharmaceutical Drug Molecules. Asian J. Research Chem. 2021; 14(1):92-96.
4. Salsa Lina Agustin, Tri Widiandani, Suko Hardjono, Bambang Tri Purwanto. QSAR of Acyl pinostrobin derivatives as Anti-breast cancer against HER-2 receptor and their ADMET properties based on in silico Study. Research Journal of Pharmacy and Technology 2022; 15(10):4641-8.
5. Yash Paul, Avinash S. Dhake, Milind Parle, Bhupinder Singh. Quantitative Structure Pharmacokinetic Relationship Studies for Drug Clearance of Quinolone Drugs. Research J. Pharm. and Tech. 2008; 1(2): 106-111.
6. Shreyash D. Kadam, Denni Mammen, Deepak S. Kadam, Sudhakar G. Patil. In silico molecular docking against C-KIT Tyrosine Kinase and ADME studies of 3-Ethyl-2-(2,3,4-trifluoro-phenylimino)-thiazolidin-4-one derivatives. Asian Journal of Research in Chemistry. 2023; 16(1):55-4. doi: 10.52711/0974-4150.2023.00010.
7. Radhika Chelamalla, Ajitha Makula. Molecular docking studies and ADMET Predictions of Pyrimidine Coumarin Scaffolds as Potential IDO Inhibitors. Asian J. Research Chem. 2017; 10(3): 331-340.
8. Nikunj Patadiya, Vipul Vaghela. Design, in-silico ADME Study and molecular docking study of novel quinoline-4-on derivatives as Factor Xa Inhibitor as Potential anti-coagulating agents. Asian Journal of Pharmaceutical Research. 2022; 12(3): 207-1. doi: 10.52711/2231-5691.2022.00034.
9. Michael Davies, Rhys D.O. Jones, Ken Grime, Rasmus Jansson-Löfmark, Adrian J. Fretland, Susanne Winiwarter, Paul Morgan, and Dermot F. McGinnity. Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades. Trends in Pharmacological Sciences. 2020; 41(6). doi:10.1016/j.tips.2020.03.004.
10. Cheng Li, Tongtong Liu, Xiaoming Cui, Annette S. USS, and K.-C. Cheng. Development of In Vitro Pharmacokinetic Screens Using Caco-2, Human Hepatocyte, and Caco-2/Human Hepatocyte Hybrid Systems for the Prediction of Oral Bioavailability in Humans. Journal of Biomolecular Screening. 2007: 1084-1091. doi: 10.1177/1087057107308892.
11. Paulo Paixaoa, Luis F. Gouveia, Jose A.G. Morais. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model. Int. J. Pharmaceutics. 2012; 429: 84–98, doi:10.1016/j.ijpharm.2012.03.019.
12. Ernesto Callegari, Manthena V.S. Varma and R. Scott Obach. Prediction of Metabolite-to-Parent Drug Exposure: Derivation and Application of a Mechanistic Static Model. Clin Transl Sci. 2020; 13: 520–528. doi:10.1111/cts.12734.
13. Olavi Pelkonen, AriTolonen, Timo Korjamo, Miia Turpeinen, Hannu Raunio. From known knowns to known unknowns: predicting in vivo drug metabolites. Bioanalysis. 2009. doi: 10.4155/bio.09.32.
14. Priyanka M. Salve, Shital V. Sonawane, Mayuri B. Patil, Rajendra K. Surawase. Dissolution and Dissolution Test Apparatus: A Review. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(3): 229-6.
15. Manju Nagpal, Pankaj Rakha, Surinder Goyal, Gitika Dhingra, Sunil Gupta. Comparison of Biorelevant and Compendial Dissolution Media and Prediction of In-vivo Plasma Profile of BCS Class II Drug. Research J. Pharma. Dosage Forms and Tech. 2010; 2(1): 37-40.
16. Sanjay Kshirsagar, Manisha Choudhari, Reshmi Sathyan, Shruti Dhore. Solubility Enhancement by Various Techniques based on Pharmaceutical and Medicinal Chemistry Approach: An Overview. Asian J. Pharm. Tech. 2019; 9(2): 141-146.
17. Manohar D. Kengar, Rohit S. Howal, Dattatray B. Aundhakar, Amit V. Nikam, Priyajit S. Hasabe. Physico-chemical Properties of Solid Drugs: A Review. Asian J. Pharm. Tech. 2019; 9 (1): 53-59.
18. Jantratid E, Janssen N, Reppas C, Dressman JB. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res. 2008 Jul; 25(7): 1663-76. doi: 10.1007/s11095-008-9569-4. Epub 2008 Apr 11. PMID: 18404251.
19. Mann J, Dressman J, Rosenblatt K, Ashworth L, Muenster U, Frank K, Hutchins P, Williams J, Klumpp L, Wielockx K, Berben P, Augustijns P, Holm R, Hofmann M, Patel S, Beato S, Ojala K, Tomaszewska I, Bruel JL, Butler J. Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study. Mol Pharm. 2017 Dec 4; 14(12): 4192-4201. doi: 10.1021/acs.molpharmaceut.7b00198. Epub 2017 Aug 23. PMID: 28737403.
20. Ina Hubatsch, Eva G E Ragnarsson and Per Artursson. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nature Protocols. 2007; 2(9): 2113. doi:10.1038/nprot.2007.303.
21. Sugano K, Hamada H, Machida M, Ushio H, Saitoh K, Terada K. Optimized conditions of bio-mimetic artificial membrane permeation assay. Int J Pharm. 2001 Oct 9; 228(1-2): 181-8. doi: 10.1016/s0378-5173(01)00845-6. PMID: 11576780.
22. Nielsen PE, Avdeef A. PAMPA--a drug absorption in vitro model 8. Apparent filter porosity and the unstirred water layer. Eur J Pharm Sci. 2004 May; 22(1): 33-41. doi: 10.1016/j.ejps.2004.02.003. PMID: 15113581.
23. Avdeef A, Artursson P, Neuhoff S, Lazorova L, Gråsjö J, Tavelin S. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method. Eur J Pharm Sci. 2005 Mar; 24(4): 333-49. doi: 10.1016/j.ejps.2004.11.011. Epub 2005 Jan 20. PMID: 15734300.
24. Bermejo M, Avdeef A, Ruiz A, Nalda R, Ruell JA, Tsinman O, González I, Fernández C, Sánchez G, Garrigues TM, Merino V. PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. Eur J Pharm Sci. 2004 Mar; 21(4): 429-41. doi: 10.1016/j.ejps.2003.10.009. PMID: 14998573.
25. Sinko, Patrick and Leesman, Glen and Amidon, Gordon. Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach. Pharmaceutical Research. 1991; 8. Doi：10.1023/A:1015892621261.